The role of the JAK/STAT pathway in the pathogenesis and treatment of post-COVID autoimmune syndromes.

Bruno L, Di Berardino M, Cafaro G, Pozzolo RD, Ceccarelli F, Shoenfeld Y, Gerli R, Bartoloni E, Perricone C

Open source

DOI
10.3389/fphar.2026.1939700
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1939700,
  title = {The role of the JAK/STAT pathway in the pathogenesis and treatment of post-COVID autoimmune syndromes.},
  author = {Bruno L and Di Berardino M and Cafaro G and Pozzolo RD and Ceccarelli F and Shoenfeld Y and Gerli R and Bartoloni E and Perricone C},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1939700},
  url = {https://doi.org/10.3389/fphar.2026.1939700}
}

RIS

TY  - JOUR
TI  - The role of the JAK/STAT pathway in the pathogenesis and treatment of post-COVID autoimmune syndromes.
AU  - Bruno L
AU  - Di Berardino M
AU  - Cafaro G
AU  - Pozzolo RD
AU  - Ceccarelli F
AU  - Shoenfeld Y
AU  - Gerli R
AU  - Bartoloni E
AU  - Perricone C
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1939700
UR  - https://doi.org/10.3389/fphar.2026.1939700
ER  - 

APA

L, B., M, D. B., G, C., RD, P., F, C., Y, S., R, G., E, B., & C, P. (2026). The role of the JAK/STAT pathway in the pathogenesis and treatment of post-COVID autoimmune syndromes.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1939700

Source records